Literature DB >> 16374237

Does smoking influence survival in cancer patients through effects on respiratory and vascular disease?

Taane G Clark1, Michael F G Murphy, Kate Hey, Mark Drury, K K Cheng, Paul Aveyard.   

Abstract

Patients with cancers caused by smoking may die because they continue to smoke even after diagnosis of a cancer caused by smoking. We investigated differences in cause-specific mortality between patients diagnosed with smoking-related and non-smoking-related cancers. The causes of death were classified as smoking-related cancer, non-smoking-related cancer, respiratory or vascular disease, and all other causes. We studied all 220 089 people diagnosed with cancer in Scotland between 1986 and 1996, aged between 20 and 85 years, with last follow-up on 31 December 1999. There was a moderate excess risk of dying from respiratory and vascular causes in those with smoking-related cancers, which did not fall with time since diagnosis, consistent with continued smoking by these patients. Mortality among cancer patients might fall if more assistance in stopping smoking was provided for patients who have smoking-related cancers.

Entities:  

Mesh:

Year:  2006        PMID: 16374237     DOI: 10.1097/01.cej.0000186634.81753.45

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

1.  Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey.

Authors:  Tung-Sung Tseng; Hui-Yi Lin; Michelle Y Martin; Ted Chen; Edward E Partridge
Journal:  J Cancer Surviv       Date:  2010-05-13       Impact factor: 4.442

2.  Reduced coenzyme Q(10) in female smokers and its association with lipid profile in a young healthy adult population.

Authors:  Maha M Al-Bazi; Mohamed F Elshal; Samir M Khoja
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

3.  Long-term survival trend after primary total laryngectomy for patients with locally advanced laryngeal carcinoma.

Authors:  Zhongyang Lin; Hanqing Lin; Yuqing Chen; Yuanteng Xu; Xihang Chen; Hui Fan; Xiaobo Wu; Xiaoying Ke; Chang Lin
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

4.  Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer.

Authors:  S Teoh; F Fiorini; B George; K A Vallis; F Van den Heuvel
Journal:  Radiother Oncol       Date:  2019-08-17       Impact factor: 6.901

5.  Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.

Authors:  C Koshiaris; P Aveyard; J Oke; R Ryan; L Szatkowski; R Stevens; A Farley
Journal:  Br J Cancer       Date:  2017-09-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.